| Literature DB >> 30716338 |
Ziyu Jiang1, Kuizhong Shan2, Jie Song3, Jingbing Liu3, Suresh Rajendran4, Arivalagan Pugazhendhi5, Joe Antony Jacob6, Baoan Chen7.
Abstract
Magnetic nanoparticles (MNPs) are promising candidates for drug delivery and treatment of various disorders. Toxicity evaluation is a critical point in the development of nanoformulations and therefore, draws considerable attention. Formulations involving individual or combinatorial nanoparticle suspensions might be used for targeted delivery and treatment. This might be a evaluated further for safety related issues considering future medications based on MNPs. Nanoparticle distribution in the body is dependent on its surface characteristics. Size, dose and routes of nanoparticle entry have to be taken into consideration for future assays.Entities:
Keywords: Drug delivery; Magnetic nanoparticles; Nanoformulation; Target specificity; Toxicity
Mesh:
Substances:
Year: 2019 PMID: 30716338 DOI: 10.1016/j.lfs.2019.01.056
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037